SCHEMBL6013594

SCHEMBL6013594

Cc1ccc(-c2ccc3ccccc3n2)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 12/20 0.67
RAB9A P51151 12/20 0.67
MEN1 O00255 5/20 0.67
KMT2A Q03164 5/20 0.67
AR P10275 2/20 0.67
KDM4E B2RXH2 9/20 0.66
ALDH1A1 P00352 7/20 0.66
SMN1; SMN2 Q16637 6/20 0.66
NFKB1 P19838 2/20 0.66
NFKB2 Q00653 2/20 0.66
RELA Q04206 2/20 0.66
MAPT P10636 6/20 0.65
HPGD P15428 3/20 0.65
HSD17B10 Q99714 3/20 0.65
CYP3A4 P08684 2/20 0.65
TP53 P04637 2/20 0.65
PKM P14618 2/20 0.65
GMNN O75496 1/20 0.65
THPO P40225 1/20 0.65
BLM P54132 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23555376 0.98 NPC1 (0.65) NPC1RAB9AMEN1KMT2AAR
SCHEMBL12112870 0.89 RAB9A (0.80) NPC1RAB9AMEN1KMT2AAR
SCHEMBL12249737 0.87 NPC1 (0.53) NPC1RAB9AMEN1KMT2AAR
SCHEMBL12386970 0.86 NPC1 (0.55) NPC1RAB9AMEN1KMT2AAR
SCHEMBL14505859 0.85 NPC1 (0.58) NPC1RAB9AMEN1KMT2AAR
Trifluoroacetic Acid SCHEMBL4479324 0.84 AR (0.54) NPC1RAB9AMEN1KMT2AAR
SCHEMBL706884 0.83 RAB9A (0.71) NPC1RAB9AMEN1KMT2AAR
SCHEMBL31571831 0.83 RAB9A (0.71) NPC1RAB9AMEN1KMT2AAR
2-Phenylquinoline SCHEMBL29399739 0.83 RAB9A (0.73) NPC1RAB9AMEN1KMT2AAR
2-Phenylquinoline SCHEMBL44999 0.83 RAB9A (0.73) NPC1RAB9AMEN1KMT2AAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111116466-B Catalytic synthesis method of polysubstituted quinoline derivative 浙江万里学院 2023-02-10 CN claimed
CN-111471009-A Preparation method and application of 2-arylquinoline derivative 安阳师范学院 2020-07-31 CN claimed
US-10125226-B2 Scale-up process of bifunctionalized triblock copolymers with secondary and tertiary amines, with application in dewatering and desalting of heavy crude oils INSTITUTO MEXICANO DEL PETROLEO (MX) 2018-11-13 US claimed
CN-105801478-B A kind of method that 2- aryl quinolines are prepared by cyclo other compounds 常州大学 2018-05-25 CN claimed
CN-107459535-A Polysubstituted quinoline coordinated iridium hybrid compound and preparation method and application thereof 南京工业大学 2017-12-12 CN claimed
US-20140364566-A1 SCALE-UP PROCESS OF BIFUNCTIONALIZED TRIBLOCK COPOLYMERS WITH SECONDARY AND TERTIARY AMINES, WITH APPLICATION IN DEWATERING AND DESALTING OF HEAVY CRUDE OILS INSTITUTO MEXICANO DEL PETROLEO (MX) 2014-12-11 US claimed
CN-119930511-A Method for synthesizing N-heterocyclic compound by manganese complex catalysis under mild condition 浙江工业大学 2025-05-06 CN disclosed
CN-115710223-B Preparation method of 3-aryl quinolinone derivative 广东工业大学 2024-05-10 CN disclosed
CN-117003695-A Preparation method of 2, 3-disubstituted quinoline derivative 广东工业大学 2023-11-07 CN disclosed
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME LAPTO CO., LTD. (KR) 2023-10-19 US disclosed
US-11770974-B2 P active materials for organic photoelectric conversion layers in organic photodiodes SONY CORPORATION (JP) 2023-09-26 US disclosed
US-11770974-B2 P active materials for organic photoelectric conversion layers in organic photodiodes SONY CORPORATION (JP) 2023-09-26 US disclosed
CN-111440181-B Dipyrazolo seven-membered oxygen heterocyclic compound containing quinoline structure and synthetic method thereof 烟台大学 2023-03-21 CN disclosed
WO-2008139287-A1 AZETIDINE DERIVATIVES AND THEIR USE AS PROSTAGLANDIN E2 ANTAGONISTS PFIZER LIMITED (GB) 2008-11-20 WO disclosed
US-20080280877-A1 Azetidines PFIZER INC 2008-11-13 US disclosed
US-20070252519-A1 Novel thiophene-containing compound and thiophene-containing compound polymer, organic electroluminescent device, production method thereof, and image display medium FUJI XEROX CO., LTD. (JP) 2007-11-01 US disclosed
US-20070252519-A1 Novel thiophene-containing compound and thiophene-containing compound polymer, organic electroluminescent device, production method thereof, and image display medium FUJI XEROX CO., LTD. (JP) 2007-11-01 US disclosed
WO-2007064773-A2 ISOTOPICALLY-LABELED BENZOTHIAZOLE COMPOUNDS AS IMAGING AGENTS FOR AMYLOIDOGENIC PROTEINS UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2007-06-07 WO disclosed
US-7115884-B1 Self-encoding fiber optic sensor TRUSTEES OF TUFTS COLLEGE (US) 2006-10-03 US disclosed
EP-0124208-B1 QUINOLINE DERIVATIVES IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1988-04-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME AOC1, ODC1, PIEZO1 NPC1 1199/4885RAB9A 3157/4885MEN1 1661/4885
US-11770974-B2 P active materials for organic photoelectric conversion layers in organic photodiodes JUP, L1CAM, EPCAM NPC1 3239/4885RAB9A 2248/4885MEN1 3399/4885
US-20080280877-A1 Azetidines PTGER2, PTGER1, PTGDR2 NPC1 3819/4885RAB9A 883/4885MEN1 929/4885
US-20070252519-A1 Novel thiophene-containing compound and thiophene-containing compound polymer, organic electroluminescent device, production method thereof, and image display medium ARL1, NOD1, NLRP1 NPC1 1769/4885RAB9A 2145/4885MEN1 3286/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.